Best Evidence to Best Practice: Implementing an Innovative Model of Nutrition Care for Patients with Head and Neck Cancer Improves Outcomes.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
19 May 2020
Historique:
received: 24 04 2020
revised: 12 05 2020
accepted: 14 05 2020
entrez: 23 5 2020
pubmed: 23 5 2020
medline: 11 2 2021
Statut: epublish

Résumé

Malnutrition is prevalent in patients with head and neck cancer (HNC), impacting outcomes. Despite publication of nutrition care evidence-based guidelines (EBGs), evidence-practice gaps exist. This study aimed to implement and evaluate the integration of a patient-centred, best-practice dietetic model of care into an HNC multidisciplinary team (MDT) to minimise the detrimental sequelae of malnutrition. A mixed-methods, pre-post study design was used to deliver key interventions underpinned by evidence-based implementation strategies to address identified barriers and facilitators to change at individual, team and system levels. A data audit of medical records established baseline adherence to EBGs and clinical parameters prior to implementation in a prospective cohort. Key interventions included a weekly Supportive Care-Led Pre-Treatment Clinic and a Nutrition Care Dashboard highlighting nutrition outcome data integrated into MDT meetings. Focus groups provided team-level evaluation of the new model of care. Economic analysis determined system-level impact. The baseline clinical audit (n = 98) revealed barriers including reactive nutrition care, lack of familiarity with EBGs or awareness of intensive nutrition care needs as well as infrastructure and dietetic resource limitations. Post-implementation data (n = 34) demonstrated improved process and clinical outcomes: pre-treatment dietitian assessment; use of a validated nutrition assessment tool before, during and after treatment. Patients receiving the new model of care were significantly more likely to complete prescribed radiotherapy and systemic therapy. Differences in mean percentage weight change were clinically relevant. At the system level, the new model of care avoided 3.92 unplanned admissions and related costs of $AUD121K per annum. Focus groups confirmed clear support at the multidisciplinary team level for continuing the new model of care. Implementing an evidence-based nutrition model of care in patients with HNC is feasible and can improve outcomes. Benefits of this model of care may be transferrable to other patient groups within cancer settings.

Identifiants

pubmed: 32438607
pii: nu12051465
doi: 10.3390/nu12051465
pmc: PMC7284331
pii:
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research Council
ID : 1092508

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMC Med Inform Decis Mak. 2008 Sep 12;8:38
pubmed: 18789150
J Am Diet Assoc. 2003 Aug;103(8):1061-72
pubmed: 12891159
J Telemed Telecare. 2012 Dec;18(8):443-6
pubmed: 23209274
J Am Diet Assoc. 2004 Dec;104(12):1878-84
pubmed: 15565085
Implement Sci. 2018 Feb 23;13(1):36
pubmed: 29475440
Clin Nutr. 2017 Oct;36(5):1187-1196
pubmed: 28689670
Support Care Cancer. 2020 Mar 26;:
pubmed: 32215737
Head Neck. 2017 May;39(5):932-939
pubmed: 28225567
Transl Behav Med. 2018 Mar 1;8(2):166-174
pubmed: 29365187
Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72
pubmed: 14960256
AMIA Annu Symp Proc. 2014 Nov 14;2014:1098-104
pubmed: 25954420
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005470
pubmed: 20238340
J Contin Educ Health Prof. 2004 Fall;24 Suppl 1:S31-7
pubmed: 15712775
Am J Clin Nutr. 2018 Dec 1;108(6):1196-1208
pubmed: 30541096
J Hum Nutr Diet. 2013 Apr;26(2):182-90
pubmed: 23336961
J Acad Nutr Diet. 2017 Feb;117(2):297-310.e47
pubmed: 27436529
BMJ. 2015 Feb 10;350:g7714
pubmed: 25670179
Cancer. 1999 Aug 1;86(3):519-27
pubmed: 10430262
BMJ Open. 2015 Jul 31;5(7):e008921
pubmed: 26231757
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
CMAJ. 1997 Aug 15;157(4):408-16
pubmed: 9275952
J Laryngol Otol. 2016 May;130(S2):S32-S40
pubmed: 27841109
J Clin Oncol. 2001 Jun 1;19(11):2886-97
pubmed: 11387362
BMJ Open. 2017 Apr 3;7(4):e013318
pubmed: 28373250
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
JPEN J Parenter Enteral Nutr. 1987 Jan-Feb;11(1):8-13
pubmed: 3820522
J Acad Nutr Diet. 2018 Apr;118(4):749-760
pubmed: 29576094
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Support Care Cancer. 2018 Jul;26(7):2167-2175
pubmed: 29374300
Lancet. 2003 Oct 11;362(9391):1225-30
pubmed: 14568747
JPEN J Parenter Enteral Nutr. 2016 Mar;40(3):355-66
pubmed: 25288589
JMIR Hum Factors. 2018 May 31;5(2):e22
pubmed: 29853440

Auteurs

Merran Findlay (M)

Cancer Services, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Chris O'Brien Lifehouse, Camperdown, NSW 2050, Australia.
Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.

Nicole M Rankin (NM)

Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.
Research in Implementation Science and eHealth, Faculty of Health Sciences, University of Sydney, Camperdown, NSW 2006, Australia.

Tim Shaw (T)

Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.
Research in Implementation Science and eHealth, Faculty of Health Sciences, University of Sydney, Camperdown, NSW 2006, Australia.

Kathryn White (K)

Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.
Cancer Nursing Research Unit, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.

Michael Boyer (M)

Chris O'Brien Lifehouse, Camperdown, NSW 2050, Australia.
Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.

Christopher Milross (C)

Chris O'Brien Lifehouse, Camperdown, NSW 2050, Australia.
Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.

Richard De Abreu Lourenço (R)

Centre for Health Economics Research and Evaluation, University of Technology Sydney, Haymarket, NSW 2000, Australia.

Chris Brown (C)

National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Camperdown, NSW 2050, Australia.

Gemma Collett (G)

Cancer Nursing Research Unit, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.

Philip Beale (P)

Cancer Services, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, NSW 2050, Australia.

Judith D Bauer (JD)

School of Human Movement and Nutrition Sciences, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH